Related Experiment Videos
Autoimmune disease--pathogenesis through molecular mimicry at the tripeptide level
Annals of the Academy of Medicine, Singapore
|October 1, 1986
Summary
Short protein segments, specifically tripeptides on larger carriers, can trigger immune responses. This finding helps explain autoimmune diseases and cross-reacting monoclonal antibodies.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Short protein segments (peptides) are increasingly recognized as capable of eliciting immune responses.
- Both sequential and conformational determinants are crucial for antigenicity.
- The role of small peptide sequences within larger protein structures in immune reactions requires further elucidation.
Purpose of the Study:
- To propose and explore the hypothesis that a tripeptide (three amino acid residues) can be antigenic when part of a larger protein carrier.
- To provide a conceptual framework for understanding autoimmune phenomena.
- To explain the cross-reactivity observed with monoclonal antibodies against non-homologous proteins.
Main Methods:
- Theoretical analysis based on the tripeptide antigenicity hypothesis.
- Computer-aided analysis of putative antigenic sites in specific proteins.
- Examination of clinical syndromes including neuropathies, hepatitis, and multiple sclerosis.
Main Results:
- The tripeptide hypothesis offers a unifying explanation for diverse immunological observations.
- Analysis supports the concept that small sequential elements within proteins can act as antigenic sites.
- The model provides insights into the molecular basis of certain autoimmune and infectious diseases.
Conclusions:
- A tripeptide sequence, when integrated into a large protein, can function as a significant antigenic determinant.
- This concept enhances understanding of autoimmune diseases and antibody cross-reactivity.
- Further investigation into tripeptide epitopes may reveal new therapeutic targets.